Archive for the ‘Genetics’ Category

EuroPLX Meetings Enter 15th Year; the 40th Meeting Now in Warsaw

Wednesday, February 4th, 2009

Dielheim, Germany: The international pharma partnering forum EuroPLX 40 Warsaw will be held at the Sheraton Warsaw Hotel & Towers in Warsaw, Poland, on June 8 and 9, 2009

Now in its 15th year, EuroPLX Meetings are regular pharma and biopharma partnering events, attended by top-level business development executives from all over the world to discuss and negotiate pharma deals in a highly organised process.

The partnering scope of EuroPLX 40 Warsaw will span from patented and generic (incl. bio-generics and biosimilars), prescription and OTC drugs, to nutraceuticals and medical devices, and will comprise development, licensing, marketing, promotion, and distribution of products. The actual focus, however, will be made up by the participating companies and, as a new feature, will be displayed as a “Dynamic Partnering Focus” on as soon as sufficient partnering information will become available.

Apart from negotiations, EuroPLX Meetings have evolved into a knowledge exchange platform where issues such as new target markets, national differences in regulatory and reimbursement practices, valuation, deal structures, portfolio planning, scenario modelling, alliance management and many others are discussed among the delegates who usually represent more than 30 countries from four to five continents.

Company owners or their family members, Chief Executive Officers, Managing Directors, Presidents, and Vice Presidents usually make up a third of the participants of EuroPLX Meetings. Directors and Heads of Business Development constitute another third. The decision power present is underscored by the size of the deals: some companies have initiated their largest deals ever at EuroPLX® (short for European Pharma License Exchange).

EuroPLX Meetings typically deliver an average of 23-24 pre-scheduled business negotiations per company, far above the mainstream partnering conference standard. They are smaller, more focused, and more affordable.

Early registration is recommended, as some previous EuroPLX Meetings had to be closed for registration even before the deadline due to overbooking. The regular fee is Euro 1,250. There is a discount of Euro 300 for early registrations by 25 March 2009, and for additional delegates (Euro 200).

Download the full agenda here.

More details on the EuroPLX website

Norbert Rau
RauCon Kurfurstenstr. 1A
69234 Dielheim, Germany
ph. ++49 6222 9807-11 (direct line)
fax ++49 6222 9807-77
URLs +

AgriGenomics World Congress 2008 29-30 September 2008, Amsterdam, The Netherlands

Monday, July 28th, 2008

Select Biosciences is proud to announce their inaugural AgriGenomics World Congress. This year’s event will take place at the NH Grand Hotel Krasnapolsky in Amsterdam.

Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organizing a two day event gathering some of the most influential players in the field from Europe, America and across the globe.

The agenda will include world leading research from renowned speakers including:

* Karen Century
Senior Scientist, Mendel Biotechnology
* Jim Dunwell Professor, University of Reading
* Dominique Job
Laboratory Head, Bayer CropScience and CNRS
* Johnathan Napier
Research Leader, Rothamsted Research
* Andrew Paterson
Distinguished Research Professor and Director of the Plant Genome Mapping Laboratory, University of Georgia
* Joseph Petolino
Senior Scientist, Dow AgroSciences
* Tatiana Tatusova
Genome Group Coordinator, National Centre for Biotechnology Information, National Institutes of Health
* And many more…

The full two day agenda includes the following sessions:

* Metabolic Engineering
* System-Based Approaches
* Informatics
* Traits & Applications

To guarantee a high attendance at this exciting event Select Biosciences will maintain their traditional low registration fees and group booking discounts.

Full conference passes include admission to all sessions and the exhibition as well as conference documentation.

Lunch, coffee breaks and the drinks reception provide ample time for networking and to continue discussions from the question and answer sessions.

The conferences division of Select Biosciences Ltd. is focused on organizing specialist biomedical meetings each year. Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.

For further information contact Stephen Mudd